n-Lorem Foundation
0 followers
‌
n-Lorem’s mission is to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotides (ASO) medicines to treat patients with ultra-rare diseases (<10 patients).
Industries
Headquarters
Employees
Links
Org chart
Stanley T. Crooke
Founder And CEO
Stanley T. Crooke
Collapse
Sarah Glass
Chief Operating Officer
C. Frank Bennett
Chief Technical Officer
Joe Gleeson
Chief Medical Officer
Julie Douville
Executive Director, ASO Discovery & Development
Amy C. Williford
Senior Director Communications And Donor Relations
Laurence Mignon
Executive Director, Clinical Development
Cedrik Ngongang
Senior Director of Medical Geneticist
